Insurance broker and financial services specialist CBG Group has raised £1.65m at 120p in today’s tough market conditions to fund growth and acquisitions.
The Manchester-based company, whose growth has already been fuelled by takeovers, has secured this new funding in a placing with institutions through Zeus Capital and Religare Hichens, Harrison. AIM-quoted CBG, which recently negotiated increased banking facilities with Royal Bank of Scotland, says it will use these and the placing proceeds to expand the business organically and seek any suitable acquisitions in insurance broking.
Chairman Laurie Turnbull claims that institutions’ willingness to increase their holdings in CBG in the midst of current financial markets turmoil ‘is a testament to our proven successful track record’. Acquisitions helped the company increase pre-tax profits 48 per cent to £930,000 in the first half of this year.
Floated at 36p in 2003 and recommend by Growth Company Investor the following year at 42.5p, CBG shares reached 191p last December, after GCI suggested partial profit taking at 142.5p, before entering choppier waters. Now 137p, valuing the company at £19.3 million, they should outperform several peers at a time of likely sector consolidation and are worth holding on to for eventual improvement.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Market cap: £19.3m
PE Forecast: n/a
Share price: 137p
Growth Company Investor is the leading magazine for investors in AIM and boasts award-winning research and analysis coverage.
Subscribe now and receive a 50% discount
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Fast-growing Alliance Pharma is to buy most of Cambridge Laboratories' trade and assets for £14.3m and £16.4m.
Investors seeking to back a business with exceptionally high earnings visibility and a burgeoning order book should look no further than Norwich-based infrastructure services specialist May Gurney.
Staff rostering software specialist Allocate, buoyed by 27% organic growth in the six months to November, aims to speed expansion with several acquisitions in coming years.